导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.79% | 1189/4982 |
| 近一周 | -1.85% | 1651/5419 |
| 近一月 | -8.49% | 4798/5423 |
| 近一季 | -10.87% | 3109/5358 |
| 近半年 | 9.51% | 1051/5131 |
| 近一年 | 18.53% | 1050/4733 |
| 近两年 | 96.95% | 944/4208 |
| 近三年 | 52.66% | 1014/3661 |
| 成立以来 | 568.83% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.49% 3671/5130 |
55.91% 884/5464 |
- - |
- - |
| 2025 | 38.53% 1568/5130 |
3.57% 2311/4624 |
1.30% 2704/4802 |
35.15% 1166/4970 |
-2.30% 2752/5130 |
| 2024 | 5.42% 1669/4618 |
-6.01% 2826/4340 |
-4.35% 2898/4442 |
17.15% 570/4550 |
0.09% 1494/4618 |
| 2023 | -13.39% 1584/4216 |
3.66% 1330/3759 |
-3.22% 1547/3909 |
-8.76% 2262/4055 |
-5.38% 2267/4209 |
| 2022 | -28.32% 2193/3578 |
-20.57% 2054/2804 |
7.46% 1501/3205 |
-11.88% 1527/3430 |
-4.70% 2541/3570 |
| 2021 | 12.79% 539/2717 |
-9.67% 1430/1745 |
20.78% 313/2232 |
-2.89% 947/2560 |
6.46% 505/2708 |
| 2020 | 62.34% 398/1596 |
-5.27% 739/1036 |
28.96% 305/1256 |
6.45% 945/1472 |
24.83% 117/1690 |
| 2019 | 47.12% 283/926 |
26.02% 834/3054 |
-5.24% 2591/3201 |
8.93% 282/939 |
13.10% 166/1014 |
| 2018 | -27.25% 365/668 |
- - |
- - |
- - |
-10.69% 2101/2977 |
| 2017 | 13.43% 251/531 |
- - |
- - |
- - |
- - |
| 2016 | -20.29% 301/455 |
- - |
- - |
- - |
- - |
| 2015 | 43.14% 227/433 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 2011 | - - |
- - |
- - |
- - |
- - |
| 2010 | - - |
- - |
- - |
- - |
- - |
| 2009 | - - |
- - |
- - |
- - |
- - |
| 2008 | - - |
- - |
- - |
- - |
- - |
| 2007 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商品质成长混合C | 1.0027 | 54.69% |
| 招商创新增长混合A | 1.0759 | 54.25% |
| 招商创新增长混合C | 1.0235 | 53.96% |
| 华泰柏瑞医疗健康A | 2.6422 | 49.29% |
| 华泰柏瑞医疗健康C | 2.5804 | 49.15% |
| 招商品质成长混合A | 1.0435 | 49.15% |
| 大摩优悦安和混合A | 0.8994 | 47.23% |
| 大摩优悦安和混合C | 0.8828 | 47.08% |
| 中信建投医药健康A | 0.7950 | 39.62% |
| 大摩健康产业混合A | 1.9440 | 32.70% |
| 华夏优势增长混合 VS. 长安宏观策略混合A(740001) |